https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=7593

No pharmaceutical opinion available for this interaction.
Lopinavir / ritonavir may induce the metabolism (UGT) and decrease the plasma concentration of Valproic acid (valproate, divalproex).
–
–
–
Possible decrease of clinical efficacy.
Monitor for treatment response.
Adjust dosage if necessary.
–
–
Valproic acid
| Reference number |
|---|
| # patients |
| HIV |
| Dose |
| Frequency |
| AUC |
| Duration (days) |
| 1623 |
|---|
| 8 |
| + |
| 400/100 mg |
| BID |
| + 38% * |
| 1623 |
|---|
| 11 |
| + |
| 250 mg |
| BID |
| 7 |
Ref #1623 : * Refers to lopinavir.
There were no significant differences in lopinavir Cmin (6.81 vs 10.7 ng/ml) or Cmax (12.4 vs 16.5 ng/ml) when given with valproic acid. Valproic acid trough not significantly
changed.
Ref #1940 : A case report of a 30 year old man with valproic acid concentrations decreased (- 48%) 21 days after starting lopinavir/ritonavir; valproic acid dosage was doubled and levels re-stabilized.